1. Home
  2. HBB vs TRDA Comparison

HBB vs TRDA Comparison

Compare HBB & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

N/A

Current Price

$32.07

Market Cap

321.2M

ML Signal

N/A

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$7.31

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HBB
TRDA
Founded
1904
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
321.2M
275.3M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
HBB
TRDA
Price
$32.07
$7.31
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
90.9K
247.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
2.75
N/A
Revenue
$606,852,000.00
$25,421,000.00
Revenue This Year
N/A
$39.97
Revenue Next Year
N/A
$50.80
P/E Ratio
$11.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.56
$5.02
52 Week High
$34.26
$16.45

Technical Indicators

Market Signals
Indicator
HBB
TRDA
Relative Strength Index (RSI) 61.42 49.63
Support Level $17.90 $5.71
Resistance Level $34.19 $7.95
Average True Range (ATR) 1.04 0.39
MACD -0.56 -0.04
Stochastic Oscillator 46.96 37.86

Price Performance

Historical Comparison
HBB
TRDA

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: